news

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

June 16, 2025 18:40 ET  | Source: Enzo Biochem, Inc. FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem,…

12 months ago

“AI and the Art Market” by Arte, with Artprice by Artmarket and analysis by Perplexity.AI Labs

PARIS, June 16, 2025 /PRNewswire/ -- This Sunday, June 15th, 2025, the Franco-German TV channel Arte broadcast the documentary "AI…

12 months ago

Introducing Bybit TradFi: Trading the World on Bybit

Bybit becomes the first major CEX to enable trading of gold, forex, global indices, stocks CFDs, and commodities in one…

12 months ago

MEXC Unveils “Proof of Trust” Campaign for Crypto Security, Audits, and User Protection

VICTORIA, Seychelles, June 16, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency exchange, has launched Proof of Trust, a comprehensive…

12 months ago

amber Launches First-Ever Global Student Housing Fest – Now Live

PUNE, India, June 16, 2025 /PRNewswire/ -- amber, a global student housing solutions provider, has launched the industry's first-ever global 'amber…

12 months ago

Astronergy sets the pace at SNEC 2025 with cutting-edge solar products and global partnerships

SHANGHAI, June 16, 2025 /PRNewswire/ -- As a global tier one solar module provider, Astronergy made a strong and impactful impression at…

12 months ago

HIMSS and Informa Markets Partner to Accelerate Digital Health Transformation with Co-Located Conferences in Malaysia for International Healthcare Week

KUALA LUMPUR, Malaysia, June 17, 2025 /PRNewswire/ -- The Healthcare Information and Management Systems Society (HIMSS) has partnered with Informa Markets…

12 months ago

Philip Morris International’s India Affiliate Reiterates its Commitment to ‘Grow Talent, Grow Business’

Fostering a growth-oriented culture- global & regional career pathways, cross-market diverse experiences, and upskilling opportunities, empowering employees' to innovate and…

12 months ago

Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241

PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical…

12 months ago

Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology

New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth LONDON, June 16,…

12 months ago